Legal & General Group’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.95M Sell
253,692
-38,776
-13% -$265K ﹤0.01% 1921
2025
Q4
$579K Buy
292,468
+69,580
+31% +$158K ﹤0.01% 2380
2025
Q3
$548K Buy
222,888
+17,410
+8% +$44.8K ﹤0.01% 2428
2025
Q2
$542K Buy
205,478
+21,715
+12% +$58.4K ﹤0.01% 2424
2025
Q1
$553K Buy
183,763
+52,399
+40% +$159K ﹤0.01% 2370
2024
Q4
$336K Hold
131,364
﹤0.01% 2586
2024
Q3
$488K Buy
131,364
+464
+0.4% +$2.15K ﹤0.01% 2470
2024
Q2
$827K Buy
130,900
+15,754
+14% +$104K ﹤0.01% 2256
2024
Q1
$618K Sell
115,146
-5,383
-4% -$24.4K ﹤0.01% 2348
2023
Q4
$605K Buy
120,529
+2,566
+2% +$8.05K ﹤0.01% 2379
2023
Q3
$199K Sell
117,963
-1,403
-1% -$2.82K ﹤0.01% 2721
2023
Q2
$332K Buy
119,366
+63,839
+115% +$181K ﹤0.01% 2591
2023
Q1
$101K Buy
55,527
+10,679
+24% +$33.2K ﹤0.01% 2773
2022
Q4
$227K Sell
44,848
-1,125
-2% -$6.18K ﹤0.01% 2557
2022
Q3
$229K Buy
45,973
+3,936
+9% +$17.9K ﹤0.01% 2573
2022
Q2
$157K Buy
42,037
+9,898
+31% +$39.8K ﹤0.01% 2719
2022
Q1
$180K Buy
32,139
+1,163
+4% +$7.13K ﹤0.01% 2707
2021
Q4
$188K Hold
30,976
﹤0.01% 2744
2021
Q3
$301K Buy
30,976
+18,555
+149% +$204K ﹤0.01% 2568
2021
Q2
$178K Buy
12,421
+2,998
+32% +$49.5K ﹤0.01% 2567
2021
Q1
$224K Sell
9,423
-8,167
-46% -$212K ﹤0.01% 2437
2020
Q4
$234K Buy
17,590
+13,832
+368% +$133K ﹤0.01% 2386
2020
Q3
$26K Sell
3,758
-829
-18% -$8.27K ﹤0.01% 2896
2020
Q2
$56K Buy
+4,587
New +$25.9K ﹤0.01% 2696
2019
Q3
Sell
-4,489
Closed -$5K 3385
2019
Q2
$5K Hold
4,489
﹤0.01% 3444
2019
Q1
$7K Hold
4,489
﹤0.01% 3287
2018
Q4
$5K Hold
4,489
﹤0.01% 3335
2018
Q3
$17K Hold
4,489
﹤0.01% 3247
2018
Q2
$14K Hold
4,489
﹤0.01% 3263
2018
Q1
$17K Sell
4,489
-447
-9% -$1.96K ﹤0.01% 3137
2017
Q4
$22K Hold
4,936
﹤0.01% 3130
2017
Q3
$27K Hold
4,936
﹤0.01% 3090
2017
Q2
$37K Buy
4,936
+2,313
+88% +$9.99K ﹤0.01% 2987
2017
Q1
$9K Sell
2,623
-601
-19% -$2.97K ﹤0.01% 3203
2016
Q4
$18K Buy
+3,224
New +$21.5K ﹤0.01% 3132

Other funds holding IBRX